Innovation Pharmaceuticals Inc (IPIX)

[petemantx]

It is my opinion that Brilacidin will set a new path to commerciality from all other drugs in the past developed by small bio startups.

This comes from Brilacidin being invented by a remarkable group of biochemists at U of Penn and the fact that it was so heavily put thru analysis via a super computer. It is night and day advanced beyond what a drug coming up thru a small startup lab could develop.

The drug is not for a specific indication as are most all other drugs. It's spectrum of indications due to its antiviral, antibiotic, and anti-inflammatory properties has never before been seen in any drug, especially one that so far has shown next to NO safety issues.

Promotion is being done currently by the government via their RBLs and the already published peer review, the upcoming Virology Conference presentation, the Military Health presentation announced today, the expected (at least IMO) HEAVY MEDIA attention it will garner upon release of human trial results, and expected EU and Russian sources promoting its use in CV worldwide.

Brilacidin is a drug for the WORLD, not just the USA. Major facilities will be brought to bear to manufacture it.

So with all the above, just what is a BP bringing to the table?

IMO not much. If a partnership should occur, the royalty percentage going to IPIX/BP should be reversed from the norm with IPIX getting the vast lion's share and the BP getting 10% or so. In the long run, the BP is still going to be making billions.